Naltrexone for severe self-harm behavior: A case report

American Journal of Psychiatry

Volumn 168, Issue 4, 2011, Pages 437-438

  Agarwal, Lauren J ^a   Berger, Christopher Eric ^a   Gill, Leia ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXONE;

ADULT; AUTOMUTILATION; BORDERLINE STATE; CASE REPORT; DISEASE RESISTANCE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; HUMAN; IMPULSE CONTROL DISORDER; LETTER; MAJOR DEPRESSION; METABOLIC SYNDROME X; PRIORITY JOURNAL; PSYCHOSIS;

ADULT; FEMALE; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; SELF MUTILATION; TREATMENT OUTCOME;

EID: 79955162714     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2010.10101493     Document Type: Letter

References (2)

1. Modesto-Lowe V, Van Kirk J: Clinical uses of naltrexone: a review of the evidence. Exp Clin Psychopharmacol 2002;10:213-227 (Pubitemid 34919930)
2. Sandman CA, Touchette PE, Marion SD, Chicz-DeMet A: The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior. Dev Psychobiol 2008;50:680-689 (Pubitemid 352748859)